Circulation, 146, 657-672 Circulation : an official journal of the American Heart Association / ed.-in-chief Ephraim Donosco 146(9), 657-672 (2022). doi:10.1161/CIRCULATIONAHA.121.057807 Hagström, E, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Danchin, N, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Liberopoulos, E, Marx, N, McGinniss, J, Manvelian, G, Pordy, R, Scemama, M, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Investigators & Bøttcher, M 2022, ' Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab ', Circulation, vol. 146, no. 9, pp. 657-672 . https://doi.org/10.1161/CIRCULATIONAHA.121.057807 Circulation, vol 146, iss 9 Circulation, 146, 9, pp. 657-672 Circulation, Philadelphia : Lippincott Williams & Wilkins, 2022, vol. 146, iss. 9, p. 657-672 Circulation, 146(9), 657-672. LIPPINCOTT WILLIAMS & WILKINS
Repositorio Universidad de Santander Universidad de Santander instacron:Universidad de Santander Circulation Circulation, 140(19), 1578-1589. LIPPINCOTT WILLIAMS & WILKINS Roe, M T, Li, Q H, Bhatt, D L, Bittner, V A, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Lopez-Jaramillo, P, Lopes, R D, Louie, M J, Moriarty, P M, Szarek, M, Vogel, R, White, H D, Zeiher, A M, Baccara-Dinet, M T, Steg, P G, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes ', Circulation, vol. 140, no. 19, pp. 1578-1589 . https://doi.org/10.1161/CIRCULATIONAHA.119.042551 Circulation, 140(19), 1578-1589. Lippincott Williams & Wilkins
Jukema, J W, Szarek, M, Zijlstra, L E, de Silva, H A, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Goodman, S G, Hanotin, C, Harrington, R A, Karpov, Y, Moryusef, A, Pordy, R, Prieto, J C, Roe, M T, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Davidsen, F, Videbaek, L & Andersen, D 2019, ' Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome : ODYSSEY OUTCOMES Trial ', Journal of the American College of Cardiology, vol. 74, no. 9, pp. 1167-1176 . https://doi.org/10.1016/j.jacc.2019.03.013
Journal of the American College of Cardiology, 74(9), 1167-1176 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Journal of the American College of Cardiology
Szarek, M, White, H D, Schwartz, G G, Alings, M, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Kimura, T, Kiss, R G, Lecorps, G, Mahaffey, K W, Moryusef, A, Pordy, R, Roe, M T, Tricoci, P, Xavier, D, Zeiher, A M, Steg, G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Larsen, J, Davidsen, F, Videbaek, L & Andersen, D 2019, ' Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial ', Journal of the American College of Cardiology, vol. 73, no. 4, pp. 387-396 . https://doi.org/10.1016/j.jacc.2018.10.039